Kobayashi Pharmaceutical Co., Ltd.
4967
주식 순위
#4484
Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries,... Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells OTC pharmaceuticals, guasi-drugs, deodorizing air fresheners, and sanitary products in Japan, the United States, Southeast Asia, and internationally. The company offers Ammeltz, an anti-inflammatory pain relief medicine; Dent, an effervescent denture cleaning agent; Ekitai Bluelet Okudake, a toilet bowl cleaner; Naicitol, a Chinese herbal medicine that promotes the breakdown and metabolism of fat; BreathCare, an oral breath freshener capsule; Netsusama sheet, a cooling gel sheet; and deodorizing air fresheners, lens cleaners, and oral hygiene products. It also manufactures and sells pharmaceuticals, fragrances, deodorants, cosmetics, health food, synthetic resin processed products, paper products, and hand warmers; and sells daily necessities. In addition, the company engages in transportation, real estate management, advertising planning and production, sales promotion and market research, promotional goods production and sales, and asset management activities, as well as in pharmacy, retail, and cleaning industries. Kobayashi Pharmaceutical Co., Ltd. was founded in 1886 and is headquartered in Osaka, Japan.
주가
$45.65
시가총액
$3.39B
변동 (1일)
-0.40%
변동 (1년)
30.30%
국가
JP
거래 Kobayashi Pharmaceutical Co., Ltd. (4967)
카테고리
Consumer Defensive
Kobayashi Pharmaceutical Co., Ltd. (4967)의 수익
Jun 2026 기준 수익 TTM: $10.86M
Kobayashi Pharmaceutical Co., Ltd.의 최신 재무 보고서에 따르면 회사의 현재 수익은 $10.86M입니다. 2024년에 회사는 $88.62M의 수익을 올렸으며 이는 2023년의 수익 $195.41M과 감소입니다. 이 페이지에 표시된 수익은 이자 및 세금 공제 전 수익으로, 즉 EBIT입니다.
Kobayashi Pharmaceutical Co., Ltd.의 수익 기록 (2005 ~ 2026)
연말 수익
| 연도 | 수익 | 변화 |
|---|---|---|
| 2026 (TTM) | $10.86M | -54.50% |
| 2025 | $23.86M | -73.08% |
| 2024 | $88.62M | -54.65% |
| 2023 | $195.41M | -8.33% |
| 2022 | $213.16M | -11.21% |
| 2021 | $240.08M | -6.94% |
| 2020 | $257.99M | 4.61% |
| 2019 | $246.62M | 6.86% |
| 2018 | $230.79M | 15.20% |
| 2017 | $200.34M | 12.22% |
| 2016 | $178.53M | 6.77% |
| 2015 | $167.22M | -12.30% |
| 2014 | $190.68M | -4.69% |
| 2013 | $200.06M | -16.27% |
| 2012 | $238.92M | 50.28% |
| 2011 | $158.98M | 2.08% |
| 2010 | $155.74M | -5.80% |
| 2009 | $165.34M | 4.35% |
| 2008 | $158.45M | 16.55% |
| 2007 | $135.95M | 14.16% |
| 2006 | $119.09M | -0.17% |
| 2005 | $119.29M | 0.00% |
유사 기업 또는 경쟁사의 수익
| 회사 | 수익 | 수익 차이 | 국가 |
|---|---|---|---|
| $20.38B | 187,592.36% |
US
|
|
| $9.83B | 90,410.36% |
FR
|
|
| $2.94B | 26,989.52% |
US
|
|
| $1.55B | 14,176.93% |
IN
|
|
| $517.00M | 4,662.08% |
US
|
